BackAugmedix Overview

Augmedix Receivables

Augmedix's receivables is $9.3M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$9.25M
↓ 1.92% YoYΔ $-181000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Augmedix Receivables History

Loading

Augmedix vs. peers: Receivables Comparison

Loading

Augmedix Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Augmedix (AUGX) FAQ

As of the most recent data (June 2024), AUGX shows a receivables of $9.3M. That compares with $9.4M in the prior-year period — down 1.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AUGX's receivables is now $9.3M (was $9.4M) — a 1.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Augmedix is outperforming or lagging.

Tracking AUGX's receivables over time shows whether Augmedix is scaling, shrinking, or reshaping that part of the business. The current reading is $9.3M That compares with $9.4M in the prior-year period — down 1.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Augmedix's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $9.3M) with ownership activity and broader fundamentals.